These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame. Tollefson L; Barnard RJ J Am Diet Assoc; 1992 May; 92(5):598-601. PubMed ID: 1573143 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of reactions to food additives: the aspartame experience. Bradstock MK; Serdula MK; Marks JS; Barnard RJ; Crane NT; Remington PL; Trowbridge FL Am J Clin Nutr; 1986 Mar; 43(3):464-9. PubMed ID: 3953484 [TBL] [Abstract][Full Text] [Related]
10. Obstacles confronting consumer advocates. An overview of health-related issues. Roberts HJ J Fla Med Assoc; 1990 Aug; 77(8):761-5. PubMed ID: 2254743 [No Abstract] [Full Text] [Related]
13. Evaluation of consumer complaints related to aspartame use. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1984 Nov; 33(43):605-7. PubMed ID: 6436658 [No Abstract] [Full Text] [Related]
14. Calculation of aspartame intake in children. Thomas-Dobersen D J Am Diet Assoc; 1989 Jun; 89(6):831-3. PubMed ID: 2723310 [No Abstract] [Full Text] [Related]
15. There really is no controversy. Samuels A Eur J Clin Nutr; 2009 Aug; 63(8):1044. PubMed ID: 18545263 [No Abstract] [Full Text] [Related]
16. Multiple chemical sensitivity: controlled scientific studies as proof of causation. Tollefson L Regul Toxicol Pharmacol; 1993 Aug; 18(1):32-43. PubMed ID: 8234917 [TBL] [Abstract][Full Text] [Related]
17. From aspartame to Xenical. A look at the FDA review process. Trissler RJ J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675 [No Abstract] [Full Text] [Related]
18. Comparison of aspartame- and fructose-sweetened layer cakes: importance of panels of users for evaluation of alternative sweeteners. Hess DA; Setser CS J Am Diet Assoc; 1986 Jul; 86(7):919-23. PubMed ID: 3722658 [TBL] [Abstract][Full Text] [Related]